Press Releases Numinus Wellness Inc.

Equities

NUMI

CA67054W1032

Market Closed - Toronto S.E. Other stock markets 15:59:59 2024-05-14 EDT			5-day change	1st Jan Change
0.075 ^CAD	-6.25%		-6.25%	-31.82%

05-07	Numinus Wellness to Focus on U.S. Operations as it Transitions Out of Canada	MT
05-07	Numinus Wellness Brief: Announces a strategic plan designed to streamline expenses and "Sharpen" focus on Higher-growth U.S. operations	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Numinus Wellness Focused on Boosting Profitability and Expanding Community Support	05-07	AQ
Cedar Clinical Research selected as clinical research site for Cybin's Phase 3 Study of CYB003	04-17	AQ
Numinus Wellness Provides Corporate Update	04-15	PR
Numinus Wellness Provides Corporate Update	04-15	AQ
Numinus Wellness Inc. Announces Second Quarter Fiscal 2024 Results	04-12	AQ
Numinus Wellness Inc. Announces Second Quarter Fiscal 2024 Results	04-12	PR
Numinus to Host Q2 Fiscal 2024 Results Conference Call on April 15, 2024	04-09	AQ
Numinus Wellness Submits Clinical Trial Application	03-20	AQ
Numinus Wellness Provides Corporate Update	03-12	PR
Numinus Wellness Congratulates MindMed on Positive Results from Phase 2B Clinical Trials of MM120 for Generalized Anxiety Disorder	03-08	AQ
Numinus Wellness Inc. Closes $6 Million Bought Deal Public Offering	02-16	AQ
Numinus Wellness Inc. Congratulates Lykos Therapeutics on FDA Acceptance of New Drug Application for MDMA-Assisted Therapy for PTSD	02-14	AQ
Canadian Investment Regulatory Organization Trade Resumption - NUMI	02-02	AQ
Canadian Investment Regulatory Organization Trading Halt - NUMI	02-01	AQ
Numinus Wellness Inc. Announces $6 Million Bought Deal Public Offering with Leads Orders from MAPS and Integrated V.C.	02-01	GL
/C O R R E C T I O N from Source -- Numinus Wellness Inc./	02-01	AQ
Numinus Wellness Divests of Holdings in Alto Neuroscience Inc.	02-01	PR
Numinus Wellness Inc. Announces First Quarter Fiscal 2024 Results	01-15	PR
Numinus to Host Q1 Fiscal 2024 Results Conference Call on January 15, 2024	01-02	AQ
Cedar Clinical Research selected as clinical research site for Beckley Psytech's Phase 2b Study	12-15	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Numinus Wellness Inc.

Equities

NUMI

CA67054W1032

Press Releases

Filters